Literature DB >> 12215472

Mitogenic activity of oxidized lipoprotein (a) on human vascular smooth muscle cells.

Norio Komai1, Ryuichi Morishita, Shingo Yamada, Mitsuru Oishi, Sota Iguchi, Motokuni Aoki, Minako Sasaki, Ikunosuke Sakurabayashi, Jitsuo Higaki, Toshio Ogihara.   

Abstract

Although oxidized lipoproteins may play an important role in the progression of atherosclerosis, no report has mentioned the significance of oxidized lipoprotein (a) (Lp[a]) in the pathogenesis of cardiovascular disease. Initially, we compared the mitogenic actions of Lp(a) and oxidized Lp(a) on human vascular smooth muscle cells (VSMC). Lp(a) significantly stimulated the growth of human VSMC in a dose-dependent manner, whereas oxidized Lp(a) showed a stronger stimulatory action on VSMC growth than native Lp(a). Interestingly, antioxidants probucol and fluvastatin inhibited the oxidation of Lp(a). Moreover, the stimulatory effect of oxidized Lp(a) on human VSMC growth was significantly inhibited by probucol. Finally, we elucidated the molecular mechanisms of how Lp(a) stimulated the growth of VSMC. Extracellular signal-regulated kinase (ERK), as those controlled by kinases, modulate critical cellular functions such as cell growth, differentiation, and apoptosis, was transiently phosphorylated by oxidized Lp(a) as well as native Lp(a) from 5 minutes, and the phosphorylation disappeared within 30 minutes. The degree of ERK phosphorylation by oxidized Lp(a) was much higher than that by native Lp(a). Administration of a specific inhibitor of MEK, PD 98059, significantly attenuated VSMC growth induced by native Lp(a) or oxidized Lp(a) in a dose-dependent manner (P<0.01). The current study demonstrated that oxidized Lp(a) is more potent than native Lp(a) in stimulating VSMC growth. Oxidized Lp(a) may play an important role in the pathogenesis of vascular disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12215472     DOI: 10.1161/01.hyp.0000029974.50905.b4

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  12 in total

Review 1.  Research progress of vasculopathy in portal hypertension.

Authors:  Tao Li; Zhen Yang
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

2.  Oxidized lipoprotein(a) and cardio-ankle vascular index (CAVI) in hypertensive subjects.

Authors:  Kazuhiko Kotani; Shingo Yamada; Toshiyuki Yamada; Kazuomi Kario; Nobuyuki Taniguchi
Journal:  Heart Vessels       Date:  2012-06-19       Impact factor: 2.037

3.  Splenic vasculopathy in portal hypertension patients.

Authors:  Tao Li; Ji-Yuan Ni; Yan-Wu Qi; Hai-Yang Li; Tong Zhang; Zhen Yang
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

4.  Early atherosclerotic lesions in infancy: role of parental cigarette smoking.

Authors:  Luigi Matturri; Giulia Ottaviani; Anna Maria Lavezzi
Journal:  Virchows Arch       Date:  2005-06-10       Impact factor: 4.064

5.  The association between blood glucose and oxidized lipoprotein(a) in healthy young women.

Authors:  Kazuhiko Kotani; Shingo Yamada; Shuumarjav Uurtuya; Toshiyuki Yamada; Nobuyuki Taniguchi; Ikunosuke Sakurabayashi
Journal:  Lipids Health Dis       Date:  2010-09-21       Impact factor: 3.876

Review 6.  LDL-apheresis: technical and clinical aspects.

Authors:  Rolf Bambauer; Carolin Bambauer; Boris Lehmann; Reinhard Latza; Ralf Schiel
Journal:  ScientificWorldJournal       Date:  2012-04-30

7.  Lipoprotein(a): Cellular Effects and Molecular Mechanisms.

Authors:  Kirsten Riches; Karen E Porter
Journal:  Cholesterol       Date:  2012-09-06

Review 8.  Lipoprotein(a) in cardiovascular diseases.

Authors:  Michele Malaguarnera; Marco Vacante; Cristina Russo; Giulia Malaguarnera; Tijana Antic; Lucia Malaguarnera; Rita Bella; Giovanni Pennisi; Fabio Galvano; Alessandro Frigiola
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

9.  Apolipoprotein(a) acts as a chemorepellent to human vascular smooth muscle cells via integrin αVβ3 and RhoA/ROCK-mediated mechanisms.

Authors:  Kirsten Riches; Larissa Franklin; Azhar Maqbool; Michelle Peckham; Matthew Adams; Jacquelyn Bond; Philip Warburton; Nicole T Feric; Marlys L Koschinsky; David J O'Regan; Stephen G Ball; Neil A Turner; Karen E Porter
Journal:  Int J Biochem Cell Biol       Date:  2013-05-31       Impact factor: 5.085

10.  Minimally modified LDL upregulates endothelin type A receptors in rat coronary arterial smooth muscle cells.

Authors:  Jie Li; Lei Cao; Cang-Bao Xu; Jun-Jie Wang; Yong-Xiao Cao
Journal:  Mediators Inflamm       Date:  2013-06-19       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.